-
Share
23 Posts.
5
24/05/21
12:37
Share
Back of the napkin Covid test valuation.
Assume:
Price per test, US$10.00
Manufacturing cost, $3.33
Distributor margin, $3.33
Gross Profit per unit, $3.34
Operon Sales
20,000,000 @ GP $3.34
$66,800,000
Anteo (direct) Sales
12,000,000 @ (say) GP $6.34
$76,080,000
Total Gross Profit
$142,880,000
P/E ratio of 20x
COVID-19 Business Value
$2,857,600,000
Shares on issue
1,900,000,000
Value per Share.
$1.50 Risk adjusted
@ 50%. $0.75
Thoughts?
-
